1. Home
  2. MKC vs NBIX Comparison

MKC vs NBIX Comparison

Compare MKC & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo McCormick & Company Incorporated

MKC

McCormick & Company Incorporated

HOLD

Current Price

$46.06

Market Cap

12.9B

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$158.38

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MKC
NBIX
Founded
1889
1992
Country
United States
United States
Employees
14100
N/A
Industry
Packaged Foods
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.9B
13.2B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
MKC
NBIX
Price
$46.06
$158.38
Analyst Decision
Buy
Strong Buy
Analyst Count
10
22
Target Price
$67.00
$180.91
AVG Volume (30 Days)
3.3M
1.2M
Earning Date
03-31-2026
05-05-2026
Dividend Yield
3.80%
N/A
EPS Growth
N/A
41.95
EPS
N/A
1.91
Revenue
N/A
$161,626,000.00
Revenue This Year
$16.24
$24.73
Revenue Next Year
$3.71
$13.14
P/E Ratio
$23.90
$83.53
Revenue Growth
N/A
977.51
52 Week Low
$44.82
$117.84
52 Week High
$78.03
$162.39

Technical Indicators

Market Signals
Indicator
MKC
NBIX
Relative Strength Index (RSI) 31.46 75.63
Support Level N/A $125.54
Resistance Level $69.16 $158.92
Average True Range (ATR) 1.37 4.50
MACD -0.16 2.55
Stochastic Oscillator 16.88 89.50

Price Performance

Historical Comparison
MKC
NBIX

About MKC McCormick & Company Incorporated

In its 135-plus-year history, McCormick has become the leading global manufacturer of spices, herbs, extracts, seasonings, and other flavorings. In addition to its namesake brand, the firm's portfolio includes Old Bay, Zatarain's, Thai Kitchen, Frank's RedHot, French's, and Cholula. This mix will be complemented by the pending addition of Unilever's food brands, primarily Knorr cooking aids and Hellmann's mayonnaise. After the deal close, the combined business is slated to generate 70% of sales from consumers and 30% from restaurants and other packaged food and beverage manufacturers. Around 40% of sales are slated to come from faster-growing emerging markets, with Europe (23%) and North America (36%) accounting for the remainder.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: